ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Sustainable Clinical Trials Through eClinical Innovation

  Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.

• Collecting Trial Data From Patients In Remote Areas

  Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.

• Checklist: Essential Features Of A Future-Proof Automated eTMF System

  During evaluation of eTMF systems, use this information to ensure your selection will deliver complete, timely, and high quality TMFs now and in the future.

• Increase Participant Diversity With eClinical Tools

  The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.

• Driving Successful Obesity Drug Development With GLP-1 Agonists

  GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.

• Accelerating Study Startups: Drive Efficiency From Protocol To Go-Live

  Speed up trial launches and maintain predictable timelines by leveraging a modern, integrated approach to eCOA setup that reduces complexity.

• How Can Sponsors Enable Research-Naïve Clinical Trial Sites

  Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.

• Hope In The Dark: Value In Alzheimer's Disease Research And Treatment

  The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.

• Embracing Accessibility: The Future Of Clinical Trials

  Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.

• Build Versus Buy: What's The Best Tech Tool For Study Activation?

  In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.